Enterprise Ventures in Autism Therapeutics

The list below is of commercial companies that are in the process of developing novel therapies and treatments for autism and related neurodevelopmental and neurological disorders.

Please note that the companies listed on this page are not directly related to the BRAIN Foundation. We attempt to give as much details as possible below, but if you have any further questions about the products, services, ongoing trials, availability of therapeutic options etc please enquire directly with the company/organization.

Axial Therapeutics

Development of gut-restricted therapeutics for CNS disorders…

BIOROSA

Developing blood biomarkers for early diagnosis of autism…

BIOVERGE

Investment platform specializing in innovative healthcare startups…

FINCH THERAPEUTICS

Developing a novel therapeutic agent for autism +GI symptoms…

JelikaLite

Developing an intelligent medical device for autism spectrum…

MARABio Systems

Developing tests for establishing autism risk and early diagnosis…

STALICLA

Omics-based precision medicine drug development for autism…

Wave Neuroscience

Improving brain function with non-invasive neuromodulation…

YAMO PHARMA

Developing a novel therapy for core symptoms of ASD…

Zynerba

Next-generation pharmaceutical grade cannabinoid therapeutics…

Are you a commercial enterprise developing therapeutics with potential for autism?

If you are a company that is developing products or services with a potential for FDA-approval for core or comorbid symptoms of autism, we would like to hear from you.

We are interested in enterprise of any size and development stage – whether you are a startup with a great idea in need of a funding boost, or an established venture with large-scale clinical trials for your product, please get in touch to discuss how BRAIN could help you advance your efforts. Write to us on info@brainfoundation.org.